Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Alta Advisers Ltd

Alta Advisers Ltd raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 42.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,681 shares of the medical equipment provider's stock after purchasing an additional 500 shares during the quarter. Alta Advisers Ltd's holdings in Intuitive Surgical were worth $833,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its position in Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the period. Geode Capital Management LLC lifted its stake in Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after acquiring an additional 243,802 shares in the last quarter. Norges Bank purchased a new position in Intuitive Surgical during the 4th quarter valued at about $2,401,493,000. Invesco Ltd. grew its holdings in shares of Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after purchasing an additional 295,025 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after acquiring an additional 494,496 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In other news, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the sale, the executive vice president owned 2,245 shares of the company's stock, valued at $1,152,089.10. The trade was a 43.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ISRG shares. Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Barclays decreased their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their price objective for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Truist Financial dropped their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Finally, Evercore ISI lowered their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

Intuitive Surgical Trading Down 1.0%

Shares of NASDAQ:ISRG traded down $5.42 during midday trading on Tuesday, hitting $537.99. The stock had a trading volume of 1,649,278 shares, compared to its average volume of 1,669,334. The company has a market capitalization of $192.83 billion, a PE ratio of 78.88, a P/E/G ratio of 5.66 and a beta of 1.67. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The stock has a 50 day moving average price of $533.58 and a two-hundred day moving average price of $536.72.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the business posted $1.50 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.